No significant differences in treatment or outcomes were found between most Medicare Advantage (MA) and fee-for-service (FFS) beneficiaries with breast cancer, but Black patients with FFS Medicare ...

Findings from the interviews offer insight into potential strategies for reducing binge eating among patients who experience ...

Data from a meta-analysis of 8 observational studies accounting for more than 26 million people across the globe were ...

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Experts at leading health care conferences last month called for further research into the health effects of microplastics ...

The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer.

None of the eteplirsen-treated patients reached a left ventricular ejection fraction below 50% compared with 22.1% of ...

Pediatric patients with prior SARS-CoV-2 infection had a higher risk of adverse postacute kidney outcomes, such as new-onset ...

The California-based entities plan to offer new Medicare Advantage (MA) products in select counties by this fall.

Richard Lafayette, MD, FACP, Stanford University Medical Center, explains the significance of this second approval in a month for proteinuria reduction.

Julie Parsons, MD, is a professor of clinical pediatrics and neurology and co-director of the Neuromuscular Clinic at Children’s Hospital Colorado ...